🧬 SinoBioData Academic Portal
Open AccessDOI: 10.1186/s13287-026-05044-yOriginal Research

Stem cell-driven biomedical technologies for tooth regeneration: engineering scaffolds, organoid models, and molecular targeted strategies

Zhaorui Jin¹,Bo Yang¹,Siyuan Zhang¹,Zhi Liu¹,Yuhao Wang¹,An Lin¹,Kexin Yang¹,Mei Yu¹,Weidong Tian¹,Fangjun HuoĀ¹āœ‰

• State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Engineering Research Center of Oral Translational Medicine, National Engineering Laboratory for Oral Regenerative Medicine, West China Hospital of Stomatology, Sichuan University

Read Executive PreviewQuick FAQ
Stem cell-driven biomedical technologies for tooth regeneration: engineering scaffolds, organoid models, and molecular targeted strategies
Graphical Abstract / Figure
Published In
Stem Cell Research & Therapy
Published:January 15, 2026Edition:Vol 17, Issue 1 • pp. 100-112Citation:Zhaorui Jin et al. (2026), Stem Cell Research & Therapy
Impact FactorPremier Chinese Biomedical Journal indexed in SinoBioData: Stem Cell Research & Therapy (å¹²ē»†čƒžē ”ē©¶äøŽč½¬åŒ–).
Sponsored Research Partner

Key Takeaways & Executive Findings

  • •• Stem cell-based scaffold-guided strategies combine dental stem cells with bioactive materials to promote odontogenic differentiation and periodontal regeneration. • Tooth organoids and bioengineered tooth germs recapitulate epithelial-mesenchymal interactions, providing platforms for modeling human odontogenesis. • Molecular targeted therapies, including anti-USAG-1 antibodies, modulate key signaling pathways (Wnt, BMP, FGF, TGF-β) to stimulate endogenous tooth regeneration. • Future directions include smart biomaterials, gene/protein-based targeting, organoid-guided regeneration, and iPSC-enabled personalized therapies for clinical translation.
Sponsored Research Highlight

Abstract

Tooth loss remains a major unmet clinical challenge, and current prosthetic approaches cannot restore the biological complexity, sensory function, or regenerative capacity of natural teeth. Recent progress in stem cell biology, developmental engineering, and regenerative biomaterials has opened new possibilities for biological tooth regeneration. This review integrates advances across three major research domains that together define the current landscape of translational regenerative dentistry. First, we discuss stem cell-based, scaffold-guided strategies for tooth regeneration. These approaches combine dental and nondental stem cells, including DPSCs, SCAPs, PDLSCs, SHED, and iPSC-derived lineages, with bioactive materials such as HA/TCP ceramics, dentin-derived extracellular matrix scaffolds, and natural or synthetic polymers to promote odontogenic differentiation, vascularization, and periodontal attachment. Second, we summarize emerging tooth organoid and bioengineered tooth germ technologies that recapitulate epithelial–mesenchymal interactions and enable controlled reconstruction of dentin–pulp and periodontal compartments for modeling human odontogenesis. Third, we highlight molecular regulation-driven therapeutic strategies, focusing on the modulation of Wnt, BMP, FGF, TGF-β, and USAG-1 pathways to stimulate endogenous tooth regeneration and correct developmental defects. Despite marked progress, challenges remain, including stable neurovascular integration, optimization of stem cell–material crosstalk, precise control of spatiotemporal signaling, and long-term functional stability in vivo. Finally, we outline future directions involving smart biomaterials, gene- and protein-based molecular targeting, organoid-guided regeneration, and iPSC-enabled personalized therapies, which may further accelerate the clinical translation of stem cell-based tooth regeneration.

1. Introduction

Tooth development in humans is a highly orchestrated process involving sequential epithelial–mesenchymal interactions, tightly regulated molecular signaling pathways (e.g., BMP, FGF, and Wnt), and coordinated cellular differentiation events. During embryogenesis, the initiation of the dental lamina gives rise to the tooth germ, which progresses through the bud, cap, and bell stages, ultimately forming enamel, dentin, and periodontal structures. This developmental cascade ensures structural integrity and functional integration of the dentition within the craniofacial system. From an evolutionary perspective, human dentition is thecodont, heterodont, and diphyodont. Teeth are anchored in alveolar sockets, exhibit morphological specialization, and undergo only a single natural cycle of replacement. Consequently, once permanent teeth are lost, no endogenous mechanism exists for regeneration, underscoring the clinical importance of restorative and regenerative strategies.

Tooth loss arises from diverse etiologies, including developmental anomalies, dental caries, periodontal disease, and traumatic injury. Regardless of the cause, tooth loss disrupts oral homeostasis and exerts far-reaching functional, aesthetic, and psychological consequences. Epidemiological studies confirm its widespread prevalence, with a global pooled estimate of edentulism reaching approximately 22%, and as high as 32% in economically disadvantaged regions. In elderly populations, tooth loss is directly associated with frailty, impaired mastication, and malnutrition, contributing to systemic conditions such as sarcopenia and cardiovascular disease. Beyond individual health, the socioeconomic burden of edentulism is considerable: restorative treatment costs remain high, and access to advanced therapies is limited in low- and middle-income countries, further exacerbating global health inequities. These challenges highlight the urgent need for therapeutic strategies that not only restore occlusion but also contribute to long-term oral and systemic health.

SinoBioData Interactive Document Reader
Page 1–5 of Preview
100%
Download Full PDF

Loading authentic research manuscript (Pages 1–5)...

Sponsored Research Partner
Cite This Research Paper
Zhaorui Jin, Bo Yang, Siyuan Zhang, Zhi Liu, Yuhao Wang, An Lin, Kexin Yang, Mei Yu, Weidong Tian, Fangjun Huo (2026). Stem cell-driven biomedical technologies for tooth regeneration: engineering scaffolds, organoid models, and molecular targeted strategies. Stem Cell Research & Therapy. https://doi.org/10.1186/s13287-026-05044-y
SinoBioData Academic & Legal Disclaimer

Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.

Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.

Frequently Asked Questions

What are the main strategies for stem cell-based tooth regeneration?

The main strategies include scaffold-guided tissue engineering using dental stem cells (e.g., DPSCs, SCAPs, PDLSCs) combined with bioactive materials, tooth organoid and bioengineered tooth germ technologies that mimic developmental processes, and molecular targeted therapies that modulate signaling pathways such as Wnt, BMP, FGF, TGF-β, and USAG-1.

How do tooth organoids contribute to tooth regeneration research?

Tooth organoids recapitulate epithelial-mesenchymal interactions and allow controlled reconstruction of dentin-pulp and periodontal compartments, providing valuable platforms for studying human odontogenesis and testing regenerative approaches.

What is the role of USAG-1 in tooth regeneration?

USAG-1 is a molecule that inhibits tooth development. Targeted therapies, such as anti-USAG-1 antibodies, can enhance odontogenic signaling pathways, thereby stimulating endogenous tooth regeneration and potentially correcting developmental defects.

What are the current challenges in tooth regeneration?

Challenges include achieving stable neurovascular integration, optimizing stem cell-material interactions, precise spatiotemporal control of signaling, and ensuring long-term functional stability in vivo.

What future directions are proposed for tooth regeneration?

Future directions include the development of smart biomaterials, gene- and protein-based molecular targeting, organoid-guided regeneration, and iPSC-enabled personalized therapies to accelerate clinical translation.

Recommended Scientific Literature & Research Partners

Related Technical Papers & Translations

Research Paper
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.

Read Abstract & PDF
Research Paper
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.

Read Abstract & PDF
Research Paper
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.

Read Abstract & PDF